studi
nasopharyng
swab
test
compar
sensit
specif
luminex
nxtag
nxtag
respiratori
pathogen
panel
rpp
assay
luminex
respiratori
viru
panel
rvp
fast
assay
singleplex
realtim
polymeras
chain
reaction
pcr
nxtag
assay
identifi
least
one
infecti
agent
swab
test
neg
result
rvp
fast
assay
viru
identifi
nxtag
p
b
nxtag
assay
detect
rate
significantli
higher
respiratori
syncyti
viru
p
human
metapneumoviru
p
b
human
rhinovirushuman
enteroviru
p
human
adenoviru
p
b
final
nxtag
assay
identifi
pneumonia
pcrposit
sampl
howev
concord
realtim
pcr
result
low
assay
conclus
result
indic
nxtag
assay
overcom
limit
previou
luminex
assay
although
studi
need
complet
evalu
new
assay
epidem
differ
respiratori
infecti
agent
occur
simultan
winter
season
interv
sever
year
virus
frequent
involv
atyp
bacteri
pathogen
mainli
mycoplasma
pneumonia
also
play
role
principi
esposito
brown
et
al
avail
etiolog
diagnosi
respiratori
infect
essenti
plan
adequ
therapi
prevent
diffus
infect
minim
radiolog
laboratori
investig
predict
clinic
cours
diseas
precis
unfortun
clinic
symptom
diseas
caus
sever
infecti
agent
similar
regardless
infecti
agent
laboratori
assay
identifi
caus
viru
involv
epidem
esposito
principi
past
viral
bacteri
cultur
use
identif
addit
direct
fluoresc
assay
dfa
virus
howev
convent
method
sever
limit
cultur
timeand
laborintens
dfa
detect
viral
antigen
although
rapid
poor
sensit
detect
virus
ginocchio
advent
nucleic
acid
amplif
test
significantli
improv
etiolog
diagnosi
respiratori
infect
howev
test
respiratori
viral
atyp
bacteri
target
use
singleplex
polymeras
chain
reaction
pcr
expens
labori
moreov
multiplex
realtim
pcr
technolog
challeng
result
loss
sensit
multiplex
assay
involv
amplif
detect
panel
respiratori
virus
use
suspens
microarray
might
provid
practic
solut
pabbaraju
et
al
esposito
et
al
luminex
respiratori
viru
panel
rvp
fast
assay
first
version
assay
abil
simultan
identifi
target
differ
viral
type
subtyp
respiratori
secret
although
studi
report
rvp
fast
assay
may
provid
result
compar
superior
cultur
dfa
diagnosi
respiratori
viral
infect
mahoni
et
al
pabbaraju
et
al
rvp
fast
assay
critic
direct
comparison
realtim
pcr
shown
discord
result
may
occur
virus
reduc
sensit
occur
mainli
sampl
low
viral
load
choudhari
et
al
esposito
et
al
gadsbi
et
al
overcom
limit
new
assay
luminex
rvp
fast
assay
develop
assay
includ
two
control
ensur
increas
assay
perform
howev
exhibit
limit
first
version
esposito
et
al
diagnost
microbiolog
infecti
diseas
esposito
et
al
improv
viral
detect
simultan
identifi
atyp
bacteria
third
assay
develop
optim
primer
design
pcr
protocol
use
respiratori
sampl
present
studi
compar
sensit
specif
new
assay
luminex
nxtag
respiratori
pathogen
panel
rpp
assay
luminex
rvp
fast
assay
result
obtain
assay
compar
singleplex
realtim
pcr
assay
specif
design
identif
singl
infecti
agent
nasopharyng
swab
collect
otherwis
healthi
children
admit
pediatr
highli
intens
care
unit
fondazion
ircc
granda
ospedal
maggior
policlinico
milan
itali
respiratori
tract
infect
februari
evalu
respiratori
secret
collect
immedi
admiss
hospit
use
nasopharyng
flock
swab
one
swab
per
child
store
tube
contain
ml
univers
transport
medium
copan
brescia
itali
analysi
also
includ
number
nasopharyng
sampl
collect
children
communityacquir
pneumonia
previous
found
posit
pneumonia
valid
realtim
pcr
method
store
longer
month
studi
approv
ethic
committe
fondazion
ircc
granda
ospedal
maggior
policlinico
milan
itali
written
inform
consent
parent
legal
guardian
obtain
children
year
age
ask
provid
written
consent
gener
characterist
clinic
find
enrol
children
collect
archiv
previous
prepar
electron
chart
nucleic
acid
extract
swab
use
nuclisen
easymag
autom
extract
system
craponn
franc
portion
extract
test
infecti
agent
use
luminex
nxtag
assay
luminex
rvp
fast
assay
produc
luminex
molecular
diagnost
inc
toronto
canada
assay
simultan
detect
influenza
virus
nonspecif
influenza
influenza
influenza
b
viru
respiratori
syncyti
viru
rsv
parainfluenza
virus
type
hadv
human
metapneumoviru
hmpv
human
coronavirus
human
enterovirusrhinoviru
hevhrv
human
bocaviru
accord
manufactur
instruct
luminex
molecular
diagno
stic
inc
howev
nxtag
assay
slightli
less
time
consum
comparison
rvp
fast
assay
hour
vs
hour
moreov
nxtag
assay
differenti
rsv
type
rsv
type
b
detect
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophila
remain
extract
test
rsv
b
hrv
hmpv
hadv
pneumonia
use
valid
realtim
pcr
specif
agent
bosi
et
al
esposito
et
al
esposito
et
al
principi
et
al
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
cohen
kappa
coeffici
confid
interv
ci
nxtag
assay
calcul
agreement
previou
definit
cyr
franci
kappa
coeffici
higher
consid
indic
agreement
mcnemar
test
appli
compar
pair
proport
analys
perform
use
sa
version
cari
nc
usa
total
nasopharyng
swab
test
children
admit
hospit
posit
pneumonia
tabl
summar
result
obtain
use
nxtag
assay
least
one
infecti
agent
identifi
swab
tabl
singl
pathogen
detect
swab
agent
detect
swab
respect
rsv
common
pathogen
identifi
sampl
includ
singl
agent
associ
respiratori
virus
rsv
rsv
b
found
case
respect
detect
combin
one
swab
pneumonia
detect
case
found
alon
swab
associ
respiratori
virus
swab
hmpv
hrvhev
hadv
detect
swab
respect
case
found
associ
respiratori
agent
virus
detect
combin
smaller
number
swab
case
c
pneumonia
l
pneumophila
infect
detect
comparison
rvp
fast
assay
possibl
sampl
assay
produc
un
undetermin
result
one
sampl
nxtag
assay
detect
significantli
higher
number
virus
tabl
test
neg
result
rvp
fast
assay
viru
identifi
nxtag
assay
p
b
contrast
test
viru
detect
nxtag
assay
viral
agent
identifi
rvp
fast
assay
detect
rate
higher
common
virus
differ
statist
signific
rsv
p
hmpv
p
b
hrvhev
p
hadv
p
b
differ
found
influenza
parainfluenza
viru
final
nxtag
assay
identifi
pneumonia
pcrposit
sampl
tabl
present
sensit
specif
ppv
npv
nxtag
assay
rvp
fast
assay
compar
realtim
pcr
specif
rsv
b
hmpv
hrv
hadv
pneumonia
rsv
two
multiplex
assay
similar
sensit
specif
ppv
npv
moreov
exhibit
good
concord
realtim
pcr
evidenc
cohen
kappa
coeffici
higher
best
knowledg
first
studi
measur
effici
nxtag
assay
detect
respiratori
virus
atyp
bacteria
unfortun
studi
follow
limit
rel
small
number
nasopharyng
sampl
test
poor
circul
infecti
agent
studi
period
common
respiratori
virus
mycoplasma
pneumonia
could
adequ
evalu
exampl
although
number
influenza
parainfluenza
viru
posit
sampl
detect
total
number
posit
case
virus
small
possibl
draw
firm
conclus
regard
possibl
differ
abil
assay
detect
virus
moreov
remain
nucleic
acid
extract
avail
realtim
pcr
alway
suffici
permit
singleplex
realtim
pcr
determin
studi
swab
howev
avail
data
seem
indic
nxtag
assay
overcom
limit
previou
luminex
assay
although
remain
gener
less
sensit
specif
singleplex
realtim
pcr
assay
design
identifi
differ
infecti
agent
moreov
differenti
hrv
hev
remain
limit
overcom
specif
realtim
pcr
demonstr
studi
import
advanc
relat
detect
hadv
differenti
rsv
b
identif
pneumonia
previou
studi
report
sensit
rvp
fast
assay
hadv
detect
greater
esposito
et
al
present
studi
sensit
assay
hadv
even
lower
contrast
nxtag
assay
identifi
approxim
twothird
hadv
case
detect
realtim
pcr
hadv
caus
sever
even
fatal
respiratori
diseas
associ
high
risk
longterm
respiratori
sequela
campbel
et
al
thu
earli
identif
sever
respiratori
infect
caus
hadv
outbreak
may
use
monitor
circul
viru
plan
develop
adequ
prevent
therapeut
measur
similar
conclus
drawn
pneumonia
atyp
bacterium
respons
high
number
case
communityacquir
pneumonia
older
children
adolesc
young
adult
caus
sever
neurolog
complic
substanti
number
case
esposito
et
al
epidem
usual
occur
everi
year
earli
identif
patient
infect
pathogen
essenti
ensur
adequ
antibiot
treatment
limit
circul
pathogen
less
import
possibl
differenti
rsv
rsv
b
gener
rsv
type
differ
global
clinic
impact
differ
virul
report
differ
subtyp
viral
type
rsv
found
frequent
associ
lower
respiratori
tract
infect
p
b
patient
infect
rsv
requir
hospit
p
often
infect
genotyp
esposito
et
al
howev
studi
need
complet
evalu
nxtag
assay
sampl
collect
whole
year
evalu
virus
atyp
bacteria
assay
design
test
moreov
accur
cost
analys
perform
rsv
ci
confid
interv
hadv
human
adenoviru
hmpv
human
metapneumoviru
hrvhev
human
rhinovirushuman
enteroviru
npv
neg
predict
valu
ppv
posit
predict
valu
rsv
respiratori
syncyti
viru
realtim
pcr
analys
avail
subject
luminex
respiratori
viru
panel
fast
assay
analys
produc
undetermin
result
one
subject
b
specif
realtim
pcr
identifi
virus
hrv
